Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the ...
Zacks Investment Research on MSN
Wall Street analysts think West Pharmaceutical (WST) could surge 32.33%: Read this before placing a bet
Shares of West Pharmaceutical Services (WST) have gained 1.9% over the past four weeks to close the last trading session at ...
West Pharmaceutical Servs (NYSE:WST) will release its quarterly earnings report on Thursday, 2025-07-24. Here's a brief overview for investors ahead of the announcement. Analysts anticipate West ...
West Pharmaceutical Services, Inc. (NYSE:WST) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 17, the governing body of West Pharmaceutical Services, Inc. (NYSE ...
West Pharmaceutical Services, Inc. (NYSE:WST) shares are surging Thursday after the injectable pharmaceutical packaging and delivery systems company delivered a robust beat on its second-quarter 2025 ...
Shares of West Pharmaceutical Services Inc. WST rallied 1.29% to $244.22 Monday, on what proved to be an all-around poor ...
Feb 12 (Reuters) - West Pharmaceutical forecast annual profit above Wall Street estimates on Thursday, banking on higher demand for diabetes and obesity treatments that use its medical equipment. The ...
West Pharmaceutical Services, Inc. (NYSE:WST) shares surged Thursday after the injectable pharmaceutical packaging and delivery systems company’s third-quarter 2025 earnings surpassed analyst ...
West Pharmaceutical Services Inc. closed 24.36% below its 52-week high of $322.34, which the company reached on October 23rd.
My estimations suggest that the U.S. government's cuts to its healthcare system will not have a significant negative impact on West Pharmaceutical's revenues. In Q2 2025, the company's revenues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results